<DOC>
	<DOCNO>NCT00411970</DOCNO>
	<brief_summary>The aim present study compare functional clinical difference advantage standard operate system newly develop even small system par plana vitrectomy . The present study may work possible advantage disadvantage routinely use 20-gauge vitrectomy system newly develop 23-gauge device .</brief_summary>
	<brief_title>20- Versus 23- Gauge System Pars Plana Vitrectomy</brief_title>
	<detailed_description>60 patient randomize 2 group 30 . All operate general anesthesia , vitrectomized cataract extract phacoemulsification indicate . Preoperative postoper5ative control day 1,2,3 week 1 , month 1,3 12 perform . Parameters interest : postoperative conjunctival injection , pain , eye pressure , complication intra- postoperative well duration surgery divide opening time , vitrectomy time , retinal manipulation time , close time .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Vitreous Hemorrhage</mesh_term>
	<mesh_term>Temazepam</mesh_term>
	<criteria>Over 18 year age Written form consent Vitreous retinal pathology require surgery Previous history vitreous retinal surgery Pregnant breastfeed woman Prohibiting general medical condition diseases No informed consent sign Under 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>23 gauge par plana vitrectomy</keyword>
	<keyword>conjunctival erythema injection</keyword>
	<keyword>20 gauge par plana vitrectomy</keyword>
	<keyword>vitreous retinal surgery</keyword>
</DOC>